Please wait a minute...
Reviews in Cardiovascular Medicine  2021, Vol. 22 Issue (3): 545-546     DOI: 10.31083/j.rcm2203063
Editorial | Next articles
Role of hydroxychloroquine in multidrug treatment of COVID-19
Peter A. McCullough1, *(), Raphael B. Stricker2, Harvey A. Risch3
1Truth for Health Foundation, Tucson, AZ, USA
2Union Square Medical Associates, San Francisco, CA, USA
3Yale School of Public Health, New Haven, CT 06510, USA
Download:  PDF(146KB)  ( 2464 ) Full text   ( 1237 )
Export:  BibTeX | EndNote (RIS)      
Key words:  SARS-CoV-2      COVID-19      Hydroxychloroquine      Ambulatory treatment      Mortality     
Submitted:  16 September 2021      Accepted:  17 September 2021      Published:  24 September 2021     
*Corresponding Author(s):  Peter A. McCullough     E-mail:  Peteramccullough@gmail.com

Cite this article: 

Peter A. McCullough, Raphael B. Stricker, Harvey A. Risch. Role of hydroxychloroquine in multidrug treatment of COVID-19. Reviews in Cardiovascular Medicine, 2021, 22(3): 545-546.

URL: 

https://rcm.imrpress.com/EN/10.31083/j.rcm2203063     OR     https://rcm.imrpress.com/EN/Y2021/V22/I3/545

[1] Matteo Beltrami, Simone Bartolini, Massimo Milli, Alberto Palazzuoli. The relevance of specific heart failure outpatient programs in the COVID era: an appropriate model for every disease[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 677-690.
[2] Yaowang Lin, Yang Chen, Jie Yuan, Xinli Pang, Huadong Liu, Shaohong Dong, Qiuling Chen. Intravenous morphine use in acute heart failure increases adverse outcomes: a meta-analysis[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 865-872.
[3] Wanting Wang, Zhaoqiang Feng, Jinghui Bai. Effects of alirocumab on cardiovascular events and all-cause mortality: a systematic review and meta-analysis[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 873-881.
[4] Yaowang Lin, Feng Liu, Shuying Gong, Bihong Liao, Huadong Liu, Jie Yuan, Danqing Yu, Haiyan Qin, Meishan Wu, Shaohong Dong. Validity of SOFA score as a prognostic tool for critically ill elderly patients with acute infective endocarditis[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 967-973.
[5] Xinghui Li, Zhihe Da, Xiaolan Ren, Yan Qiao, Ping Xie, Xiaolong Sun, Lijun Wang, Junxian Han, Yongfeng Hua. Trends and distribution of coronary heart disease mortality rate in Hexi Corridor, Gansu, China from 2006 to 2015[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 1003-1008.
[6] Matthieu MILLION, Jean-Christophe LAGIER, Hervé TISSOT-DUPONT, Isabelle RAVAUX, Catherine DHIVER, Christelle TOMEI, Nadim CASSIR, Léa DELORME, Sébastien CORTAREDONA, Sophie AMRANE, Camille AUBRY, Karim BENDAMARDJI, Cyril BERENGER, Barbara DOUDIER, Sophie EDOUARD, Marie HOCQUART, Morgane MAILHE, Coralie PORCHETO, Piseth SENG, Catherine TRIQUET, Stéphanie GENTILE, Elisabeth JOUVE, Audrey GIRAUD-GATINEAU, Herve CHAUDET, Laurence CAMOIN-JAU, Philippe COLSON, Philippe GAUTRET, Pierre-Edouard FOURNIER, Baptiste MAILLE, Jean-Claude DEHARO, Paul HABERT, Jean-Yves GAUBERT, Alexis JACQUIER, Stéphane HONORE, Katell GUILLON-LORVELLEC, Yolande OBADIA, Philippe PAROLA, Philippe BROUQUI, Didier RAOULT. Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 1063-1072.
[7] Lee Stoner, Mark Faghy, Ryan Conners. COVID-19 infection and cardiometabolic complications: short- and long-term treatment and management considerations[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 263-265.
[8] Edoardo Pancaldi, Greta Pascariello, Giuliana Cimino, Angelica Cersosimo, Ludovica Amore, Fabio Alghisi, Nicola Bernardi, Emiliano Calvi, Carlo Mario Lombardi, Enrico Vizzardi, Marco Metra. Thrombotic risk in patients with COVID-19[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 277-286.
[9] Ibrahim AlShahrani, Jagadish Hosmani, Vidya Gurram Shankar, Abdulaziz AlShahrani, Rafi Ahmad Togoo, Syed M Yassin, Shahrukh Khan, Shankargouda Patil. COVID-19 and cardiovascular system—a comprehensive review[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 343-351.
[10] Agata Bielecka-Dabrowa, Anna Cichocka-Radwan, Joanna Lewek, Filip Pawliczak, Marek Maciejewski, Maciej Banach. Cardiac manifestations of COVID-19[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 365-371.
[11] Paulino Alvarez, Alex Sianis, Jessica Brown, Abbas Ali, Alexandros Briasoulis. Chronic disease management in heart failure: focus on telemedicine and remote monitoring[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 403-413.
[12] Rosa Agra-Bermejo, Alberto Cordero, Pedro Rigueiro Veloso, Diego Iglesias Álvarez, Belen Álvarez Álvarez, Brais Díaz, Leyre Alvarez Rodríguez, Charigan Abou-Jokh, Belén Cid Álvarez, Jose R. González-Juanatey, Jose M García Acuña. Long term prognostic benefit of complete revascularization in elderly presenting with NSTEMI: real world evidence[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 475-482.
[13] Yu-Hao Zhao, Lei Zhao, Xin-Chun Yang, Pan Wang. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 159-165.
[14] Farah Yasmin, Syed Muhammad Shujauddin, Aisha Naeem, Adina Jabeen, Syed Muhammad Ismail Shah, Rohan Kumar Ochani, Osama Mohiuddin, Anosh Aslam Khan, Sumeen Jalees, Aminah Abdul Razzack, Shiza Salman, Shuja Abdul Karim Khan, Ahmad Mustafa, Hassan Mehmood Lak. Exploring the impact of the COVID-19 pandemic on provision of cardiology services: a scoping review[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 83-95.
[15] Qing Lu, Jiu-Long Wang, Zhi-Nan Chen, Wen-Bo Fu, Hui-Jian Liu, Shi-Fang Ding. The impact of COVID-19 on short-term prognosis of ST-segment elevation myocardial infarction patients receiving primary percutaneous coronary intervention in Wuhan China[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 247-256.
No Suggested Reading articles found!